Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 27.57B | 26.32B | 26.17B | 20.23B | 19.23B |
Gross Profit | 5.42B | 5.28B | 5.01B | 3.46B | 3.67B |
EBITDA | 3.63B | 3.89B | 3.26B | 2.12B | 1.84B |
Net Income | 1.51B | 1.77B | 1.30B | 521.26M | 288.41M |
Balance Sheet | |||||
Total Assets | 31.03B | 29.48B | 25.94B | 24.70B | 23.14B |
Cash, Cash Equivalents and Short-Term Investments | 10.37B | 10.26B | 8.76B | 7.97B | 8.11B |
Total Debt | 6.65B | 5.25B | 4.86B | 5.28B | 6.08B |
Total Liabilities | 11.72B | 10.57B | 9.72B | 10.17B | 10.39B |
Stockholders Equity | 18.37B | 17.96B | 15.34B | 13.74B | 12.01B |
Cash Flow | |||||
Free Cash Flow | -388.72M | 1.06B | 1.21B | 99.29M | 1.08B |
Operating Cash Flow | 2.27B | 3.86B | 2.59B | 1.43B | 1.99B |
Investing Cash Flow | -2.50B | -4.00B | -918.48M | -1.23B | -1.59B |
Financing Cash Flow | 379.51M | -237.03M | -746.61M | -1.04B | -175.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥11.60B | 7.82 | 5.81% | 6.38% | -23.94% | ||
75 Outperform | ¥9.96B | 53.98 | 5.84% | -2.65% | -74.99% | ||
73 Outperform | ¥8.92B | 4.32 | 5.08% | 2.22% | 28.89% | ||
68 Neutral | ¥13.19B | 21.21 | 1.72% | 1.49% | -26.82% | ||
67 Neutral | ¥11.98B | 13.87 | 3.15% | 6.68% | -5.98% | ||
64 Neutral | ¥10.28B | 14.92 | 4.83% | 8.68% | 859.21% | ||
61 Neutral | $35.87B | 6.13 | -9.30% | 2.06% | 7.63% | -6.38% |